TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
出版年份 2016 全文链接
标题
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-23
DOI
10.1038/srep37652
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- L1CAM is an independent predictor of poor survival in endometrial cancer — An analysis of The Cancer Genome Atlas (TCGA)
- (2016) Thanh H. Dellinger et al. GYNECOLOGIC ONCOLOGY
- TRX-E-002-1 Induces c-Jun–Dependent Apoptosis in Ovarian Cancer Stem Cells and Prevents Recurrence In Vivo
- (2016) Ayesha B. Alvero et al. MOLECULAR CANCER THERAPEUTICS
- Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
- (2016) Samira Abdel Azim et al. Oncotarget
- Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells
- (2016) Nal Ae Yoon et al. Oncotarget
- Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma
- (2016) Hui-Hui Cao et al. Scientific Reports
- Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis
- (2016) Saber Imani et al. Scientific Reports
- Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden
- (2015) James Finlay et al. Nanomedicine-Nanotechnology Biology and Medicine
- MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1
- (2015) Yancheng Lin et al. Scientific Reports
- RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
- (2015) James Finlay et al. Biomed Research International
- Slug-Dependent Upregulation of L1CAM Is Responsible for the Increased Invasion Potential of Pancreatic Cancer Cells following Long-Term 5-FU Treatment
- (2015) Kaja Lund et al. PLoS One
- Twist Modulates Breast Cancer Stem Cells by Transcriptional Regulation of CD24 Expression
- (2015) Farhad Vesuna et al. NEOPLASIA
- Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway
- (2014) TIAN WANG et al. Oncology Letters
- Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth
- (2013) Dirk Weinspach et al. CLINICAL & EXPERIMENTAL METASTASIS
- Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening
- (2013) Alexandros Laios et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Meta-Analysis of Microarray Data IdentifiesGAS6Expression as an Independent Predictor of Poor Survival in Ovarian Cancer
- (2013) Michelle Buehler et al. Biomed Research International
- Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment
- (2013) Vinicius Craveiro et al. Cancer Medicine
- TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production
- (2012) Shan Li et al. BMC BIOLOGY
- EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation
- (2012) Helena Kiefel et al. CARCINOGENESIS
- Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
- (2012) Nicole P. Chappell et al. JOURNAL OF PROTEOME RESEARCH
- Constitutive proteasomal degradation of TWIST-1 in epithelial–ovarian cancer stem cells impacts differentiation and metastatic potential
- (2012) G Yin et al. ONCOGENE
- TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells
- (2012) H Schäfer et al. ONCOGENE
- Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum–DNA adduct repair
- (2012) K Kudo et al. ONCOGENE
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo
- (2011) Hong ONCOLOGY REPORTS
- Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells
- (2010) Masaki Shiota et al. BJU INTERNATIONAL
- L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions
- (2010) Marco Pfeifer et al. BMC MOLECULAR BIOLOGY
- AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
- (2010) E. B. Rankin et al. CANCER RESEARCH
- The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis
- (2010) Junjiang Fu et al. CELL RESEARCH
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214
- (2010) G Yin et al. ONCOGENE
- Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells
- (2009) C. E. Brown et al. CANCER RESEARCH
- Requirement for Twist1 in frontonasal and skull vault development in the mouse embryo
- (2009) Heidi Bildsoe et al. DEVELOPMENTAL BIOLOGY
- The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer
- (2009) I. Khalil et al. GYNECOLOGIC ONCOLOGY
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diagnostic Markers for Early Detection of Ovarian Cancer
- (2008) I. Visintin et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started